Custirsen

Generic Name
Custirsen
Brand Names
-
Drug Type
Biotech
Chemical Formula
-
CAS Number
890056-27-6
Unique Ingredient Identifier
L26E95NLRK
Background

Custirsen is a benzopyran with potential antineoplastic activity. Custirsen acts as a selective estrogen receptor modulator (SERM), inhibiting the proliferation of estrogen-sensitive breast cancer cells. This agent also inhibits growth and induces apoptosis of glioblastoma cells via a mechanism independent of estrogen receptor-related mechanisms. Custirsen i...

Indication

Investigated for use/treatment in brain cancer and breast cancer.

Associated Conditions
-
Associated Therapies
-

Thorough QT/QTc (Corrected QT Interval) Study to Evaluate the Effect of Custirsen on Cardiac Repolarization

First Posted Date
2013-06-11
Last Posted Date
2016-10-10
Lead Sponsor
Achieve Life Sciences
Target Recruit Count
155
Registration Number
NCT01874561
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Teva Investigational Site 10565, Lenexa, Kansas, United States

A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer

First Posted Date
2012-06-28
Last Posted Date
2016-07-01
Lead Sponsor
Achieve Life Sciences
Target Recruit Count
700
Registration Number
NCT01630733
Locations
๐Ÿ‡ช๐Ÿ‡ธ

Hospital Universitario La Paz, Madrid, Spain

๐Ÿ‡บ๐Ÿ‡ธ

University Cancer Institute, Soynton Beach, Florida, United States

๐Ÿ‡ช๐Ÿ‡ธ

Hospital Universitario Doctor Peset, Valencia, Spain

and more 78 locations

Comparison of Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With OGX-011 in Men With Prostate Cancer

First Posted Date
2010-08-25
Last Posted Date
2016-10-14
Lead Sponsor
Achieve Life Sciences
Target Recruit Count
1022
Registration Number
NCT01188187
Locations
๐Ÿ‡ณ๐Ÿ‡ฑ

Teva Investigational Site 852, Rotterdam, Netherlands

๐Ÿ‡บ๐Ÿ‡ธ

Teva Investigational Site 093, Marina del Rey, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Teva Investigational Site 100, Birmingham, Alabama, United States

and more 137 locations
ยฉ Copyright 2024. All Rights Reserved by MedPath